MATERNAL EXPOSURE VIA PARTNER DURING PREGNANCY

This adverse event was reported 64 times

These drugs are most commonly taken by patients reporting MATERNAL EXPOSURE VIA PARTNER DURING PREGNANCY:

# Drug Count
0 OFATUMUMAB 5
1 PEMBROLIZUMAB 5
2 RESMETIROM 5
3 SECUKINUMAB 5
4 FLUOXETINE HYDROCHLORIDE 4
5 AGALSIDASE BETA 3
6 BEVACIZUMAB 3
7 CABOZANTINIB 3
8 DEXAMETHASONE 3
9 DEXAMETHASONE 1.5 MG 3
See all common drugs associated with MATERNAL EXPOSURE VIA PARTNER DURING PREGNANCY

MATERNAL EXPOSURE VIA PARTNER DURING PREGNANCY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 RESMETIROM 5 0.0022
1 BRODALUMAB 2 0.0010
2 RILONACEPT 1 0.0009
3 INOTUZUMAB OZOGAMICIN 2 0.0007
4 AGALSIDASE BETA 3 0.0003
5 ASCIMINIB 1 0.0003
6 IRINOTECAN HYDROCHLORIDE 3 0.0002
7 CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES 2 0.0002
8 ENCORAFENIB 2 0.0002
9 TRIFLURIDINE AND TIPIRACIL 2 0.0002
See all drugs enriched for association with MATERNAL EXPOSURE VIA PARTNER DURING PREGNANCY